Literature DB >> 32259574

Dosage scaling of alcohol in binge exposure models in mice: An empirical assessment of the relationship between dose, alcohol exposure, and peak blood concentrations in humans and mice.

Stephen Pruett1, Wei Tan2, George E Howell2, Bindu Nanduri2.   

Abstract

Binge drinking is a remarkably prevalent behavior. In 2015, 27% of U.S. residents 18 years old or older reported at least one episode of binge drinking in the previous month. Rodent models for binge drinking are widely used to study the mechanisms by which alcohol causes a variety of adverse health effects in humans. Concerns have been raised that many binge-drinking studies in rodents involve alcohol doses that would be unrealistically high in humans. Allometric dosage scaling can be used to estimate the dose of a drug or chemical in mice that would be necessary to achieve similar biological effects at a realistic dose in humans. However, it has become apparent that no single allometric conversion factor is applicable for all drugs and chemicals, so it is necessary to evaluate each compound empirically. In the present study, we compared the area under the blood alcohol concentration vs. time curve (AUC) and the peak blood alcohol concentration following oral alcohol administration at various doses in mice and humans, using data from previously published studies. The results demonstrated that the oral dose of alcohol must be larger in mice (on a g of alcohol to kg of body weight basis) than in humans to achieve similar alcohol AUC values or to achieve similar peak concentrations in the blood. The dose required in mice was about 2-fold greater than the dose required in humans to achieve similar alcohol AUC and peak concentrations. The results shown here were substantially different from the average 5-12-fold difference between mice and humans calculated in previous studies using agents other than alcohol. Results shown here demonstrate that an empirical approach using data from several independent experiments provides information needed to determine the alcohol dose in mice that produces a similar level of exposure (AUC and peak concentration) as in humans. The results indicate that a single alcohol dose in the range of 5-6 g/kg, a range often used in mouse models for binge drinking, is not excessive when modeling human binge drinking. Results presented here illustrate that in mice both alcohol AUC and peak alcohol concentration correlate well with an important biological effect - activation of the hypothalamic-pituitary-adrenal axis - as indicated by increased corticosterone AUC values.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  allometric dosage scaling; binge drinking; mouse model; pharmacokinetics

Year:  2020        PMID: 32259574      PMCID: PMC8221372          DOI: 10.1016/j.alcohol.2020.03.011

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  46 in total

Review 1.  Translating dosages from animal models to human clinical trials--revisiting body surface area scaling.

Authors:  Otis L Blanchard; James M Smoliga
Journal:  FASEB J       Date:  2015-02-05       Impact factor: 5.191

Review 2.  Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report.

Authors:  H Tsukamoto; K Gaal; S W French
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

3.  Modeling and predicting stress-induced immunosuppression in mice using blood parameters.

Authors:  Carlton L Schwab; Ruping Fan; Qiang Zheng; L Peyton Myers; Pamela Hébert; Stephen B Pruett
Journal:  Toxicol Sci       Date:  2004-10-27       Impact factor: 4.849

4.  Mechanisms of ethanol-induced suppression of a primary antibody response in a mouse model for binge drinking.

Authors:  Y C Han; S B Pruett
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

5.  Urinary corticosterone as an indicator of stress-mediated immunological changes in rats.

Authors:  Stephen Pruett; Jean-Martin Lapointe; William Reagan; Michael Lawton; Thomas T Kawabata
Journal:  J Immunotoxicol       Date:  2008-01       Impact factor: 3.000

6.  Interspecific scaling of toxicity data.

Authors:  C C Travis; R K White
Journal:  Risk Anal       Date:  1988-03       Impact factor: 4.000

7.  Modeling and predicting immunological effects of chemical stressors: characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol.

Authors:  Stephen B Pruett; Ruping Fan; Qiang Zheng; L Peyton Myers; Pamela Hebert
Journal:  Toxicol Sci       Date:  2003-07-25       Impact factor: 4.849

8.  Temperature affects ethanol lethality in C57BL/6, 129, LS and SS mice.

Authors:  D A Finn; M Bejanian; B L Jones; P J Syapin; R L Alkana
Journal:  Pharmacol Biochem Behav       Date:  1989-10       Impact factor: 3.533

Review 9.  Role of corticosterone in immunosuppressive effects of acute ethanol exposure on Toll-like receptor mediated cytokine production.

Authors:  Mitzi Glover; Stephen B Pruett
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-04       Impact factor: 4.147

10.  Human liver alcohol dehydrogenase: ADH Indianapolis results from genetic polymorphism at the ADH2 gene locus.

Authors:  W F Bosron; L J Magnes; T K Li
Journal:  Biochem Genet       Date:  1983-08       Impact factor: 1.890

View more
  6 in total

1.  Chloride intracellular channel 4 (CLIC4) expression profile in the mouse medial prefrontal cortex and its regulation by ethanol.

Authors:  James W Bogenpohl; Rory M Weston; Taylor N Foreman; Kaitlyn E Kitchen; Michael F Miles
Journal:  Alcohol Clin Exp Res       Date:  2021-12-09       Impact factor: 3.455

2.  Binge alcohol disrupts skeletal muscle core molecular clock independent of glucocorticoids.

Authors:  Abigail L Tice; Joseph A Laudato; Michael L Rossetti; Christopher A Wolff; Karyn A Esser; Choogon Lee; Charles H Lang; Cynthia Vied; Bradley S Gordon; Jennifer L Steiner
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-09-20       Impact factor: 4.310

Review 3.  The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease.

Authors:  Aleksander J Nowak; Borna Relja
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

4.  Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models.

Authors:  Nathan D Winters; Gaurav Bedse; Anastasia A Astafyev; Toni A Patrick; Megan Altemus; Amanda J Morgan; Snigdha Mukerjee; Keenan D Johnson; Vikrant R Mahajan; Md Jashim Uddin; Philip J Kingsley; Samuel W Centanni; Cody A Siciliano; David C Samuels; Lawrence J Marnett; Danny G Winder; Sachin Patel
Journal:  J Clin Invest       Date:  2021-07-22       Impact factor: 14.808

Review 5.  Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?

Authors:  Blaine Caslin; Kailey Mohler; Shreya Thiagarajan; Esther Melamed
Journal:  Gut Microbes       Date:  2021 Jan-Dec

6.  Effects of alcohol on skeletal muscle contractile performance in male and female mice.

Authors:  Joseph A Laudato; Abigail L Tice; Jarrod A Call; Bradley S Gordon; Jennifer L Steiner
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.